EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinicopathological Characteristics of PIRADS 3 Prostate Lesion: A Retrospective Study

Bikash Bikram Thapa, Bina Basnet, Gaurav Karki, Narayan Thapa

The Surgery Journal · 10.09.2025 · 11 (CP)

DOI: 10.1055/a-2682-8456 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Surgery Journal, erschienen am 10.09.2025. Verfasst von Bikash Bikram Thapa und 3 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate carcinoma is the most common carcinoma in male. The evaluation of the suspected prostate carcinoma is based on the abnormal digital rectal examination, raised serum prostate specific antigen (PSA), followed by prostate biopsy with or without magnetic resonance imaging (MRI). The Prostate Imaging-Reporting and Data System (PIRADS) uses five-point scale (1–5), and is a global standard image acquisition, interpretation, and reporting protocol providing clinical guidelines for the management of the prostate carcinoma. PIRADS 3 is considered equivocal or intermediate risk for prostate carcinoma. The management of PIRADS 3 lesions without missing the clinically significant carcinoma and avoiding unnecessary biopsies has been a challenge to urologists. The aim of this study is to evaluate the clinicopathological characteristics, and to find out the incidence of clinically significant prostate carcinoma (csPCa) in PIRADS 3 lesion. It is a retrospective study where patients who underwent transrectal ultrasound (TRUS) guided biopsy of prostate for PIRADS 3 lesion diagnosed in multiparametric MRI (mpMRI) from October 2019 to December 2024 were reviewed and data collected for analysis. During the study period 19% (n = 34/178) had PIRADS 3 lesion. Patients with PIRADS 3 lesion had a mean age of 67 ± 8 years (mean ± standard deviation). About 41% (n = 14/34) of PIRADS 3 prostate lesion had acinar adenocarcinoma of prostate, and 20.5% (7 out of 34) had csPCa. All the csPCa cases had mpMRI lesion size of >10 mm and PSA density >0.2 ng/mL/cc. There is a significant risk of prostate carcinoma (41%) among the PIRADS 3 prostate lesion. Further evaluation and management of the PIRADS 3 lesion should be based on risk stratification based on index lesion size and PSA density.

Zitieren

APA

Thapa, B. B., Basnet, B., Karki, G., & Thapa, N. (2025). Clinicopathological Characteristics of PIRADS 3 Prostate Lesion: A Retrospective Study. The Surgery Journal, 11(CP). https://doi.org/10.1055/a-2682-8456

Vancouver

Thapa BB, Basnet B, Karki G, Thapa N. Clinicopathological Characteristics of PIRADS 3 Prostate Lesion: A Retrospective Study. The Surgery Journal. 2025;11(CP). doi:10.1055/a-2682-8456

BibTeX
@article{Thapa2025,
  author = {Thapa, Bikash Bikram and Basnet, Bina and Karki, Gaurav and Thapa, Narayan},
  title = {Clinicopathological Characteristics of PIRADS 3 Prostate Lesion: A Retrospective Study},
  journal = {The Surgery Journal},
  year = {2025},
  volume = {11},
  number = {CP},
  doi = {10.1055/a-2682-8456}
}
Kostenlos starten →